MSH|^~\&|PTH|ARH|||201911281039||ORU^R01|4115852|D|2.3|||AL|NE PID|1||AB00007299|CG2028|LABTEST^APPLE^||19930607|M||||||||||AB000119/18|9876489826 PV1|1|O OBR|1|17288|00012787^18SS-37^PTH^18SS-37^17288||||20181001||||||BONE MARROW|201810011145|S^SURGICAL SPECIMEN^SURGICAL|||||18SS-37||201911281039|||SOUT OBX|1|TX|Pathology Lab: Surrey Memorial Hospital OBX|2|TX|Phone: (604)588-3384 Fax: (604)585-5562 OBX|3|TX| OBX|4|TX|Specimen Number: 18SS-37 OBX|5|TX| OBX|6|TX|DIAGNOSES OBX|7|TX|TESTING BIZTALK 2013 OBX|8|TX| OBX|9|TX|SYNOPTIC REPORT OBX|10|TX|-------- Breast Biomarkers, 1 -------- OBX|11|TX| OBX|12|TX|SPECIMEN OBX|13|TX| Block Tested: 1A OBX|14|TX| OBX|15|TX|BREAST BIOMARKER TESTS OBX|16|TX| ER: Negative (Intensity: Negative, 0%), Allred OBX|17|TX| Score: 0/8 OBX|18|TX| PR: Negative (Intensity: Negative, 0%), Allred OBX|19|TX| Score: 0/8 OBX|20|TX| HER2 by IHC: Negative (Score 0) OBX|21|TX| OBX|22|TX|CONTROLS OBX|23|TX| ER Internal Positive Control: Present OBX|24|TX| OBX|25|TX|---------- End of Synoptic Report ---------- OBX|26|TX|-------- Breast Biomarkers, 2 -------- OBX|27|TX| OBX|28|TX|SPECIMEN OBX|29|TX| Block Tested: 1A OBX|30|TX| OBX|31|TX|BREAST BIOMARKER TESTS OBX|32|TX| ER: Positive (Intensity: Strong, 67-100%), OBX|33|TX| Allred Score: 8/8 OBX|34|TX| PR: Positive (Intensity: Strong, 67-100%), OBX|35|TX| Allred Score: 8/8 OBX|36|TX| HER2 by IHC: Positive (Score 3+) OBX|37|TX| OBX|38|TX|---------- End of Synoptic Report ---------- OBX|39|TX|-------- Breast Invasive Carcinoma, 3 -------- OBX|40|TX| OBX|41|TX|SPECIMEN OBX|42|TX| Skin, Nipple, Breast, and Skeletal muscle; OBX|43|TX| Total mastectomy; Left OBX|44|TX| OBX|45|TX|TUMOUR OBX|46|TX| Invasive Carcinoma: Present OBX|47|TX| Histologic Type: Invasive carcinoma with medullary features OBX|48|TX| Histologic Grade (Nottingham OBX|49|TX| Histologic Score) OBX|50|TX| Glandular (Acinar) / Tubular OBX|51|TX| Differentiation: Score 2 OBX|52|TX| Nuclear Pleomorphism: Score 2 OBX|53|TX| Mitotic Rate: Score 2 OBX|54|TX| Overall Nottingham Score: Grade 2 OBX|55|TX| Tumour Size: 4.0 Millimeters (mm) OBX|56|TX| Tumour Focality: Single focus of invasive carcinoma OBX|57|TX| Tumour Site: Nipple OBX|58|TX| Distance from Nipple: 4.0 cm OBX|59|TX| Lymphovascular Invasion: Present OBX|60|TX| Skin Invasion: Skin is uninvolved OBX|61|TX| In Situ Component: Present OBX|62|TX| In Situ Component Type: DCIS OBX|63|TX| Nuclear Grade: Grade I (low) OBX|64|TX| Necrosis: Not identified OBX|65|TX| DCIS Extent: Extensive OBX|66|TX| DCIS Estimated Size: 4 mm OBX|67|TX| OBX|68|TX|MARGINS OBX|69|TX| Invasive Carcinoma Margins: Negative for invasive carcinoma OBX|70|TX| Distance from Closest Margin: 20 Millimeters (mm) OBX|71|TX| Closest Margin: Superior OBX|72|TX| DCIS Margins: Negative for DCIS OBX|73|TX| Distance of DCIS from Closest OBX|74|TX| Margin: 4 Millimeters (mm) OBX|75|TX| Closest Margin: Superior OBX|76|TX| OBX|77|TX|LYMPH NODES, REGIONAL OBX|78|TX| No lymph nodes present OBX|79|TX| OBX|80|TX|PATHOLOGIC STAGE OBX|81|TX| pT1a pNX pM1 OBX|82|TX| pM Site: test OBX|83|TX| OBX|84|TX|ANCILLARY STUDIES OBX|85|TX| Best Tumour Block: test OBX|86|TX| Biomarker Testing/Results: Not performed: test OBX|87|TX| OBX|88|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|89|TX|---------- End of Synoptic Report ---------- OBX|90|TX|-------- Breast Invasive Carcinoma, 4 -------- OBX|91|TX| OBX|92|TX|SPECIMEN COMMENT OBX|93|TX| Pertains To: test OBX|94|TX| OBX|95|TX|SPECIMEN OBX|96|TX| Skin, Nipple, Breast, and Skeletal muscle; OBX|97|TX| Total mastectomy; Left OBX|98|TX| OBX|99|TX|TUMOUR OBX|100|TX| Invasive Carcinoma: Present OBX|101|TX| Histologic Type: Invasive carcinoma with medullary features OBX|102|TX| Histologic Grade (Nottingham OBX|103|TX| Histologic Score) OBX|104|TX| Glandular (Acinar) / Tubular OBX|105|TX| Differentiation: Score 2 OBX|106|TX| Nuclear Pleomorphism: Score 2 OBX|107|TX| Mitotic Rate: Score 2 OBX|108|TX| Overall Nottingham Score: Grade 2 OBX|109|TX| Tumour Size: 2.0 Millimeters (mm) OBX|110|TX| Tumour Focality: Single focus of invasive carcinoma OBX|111|TX| Tumour Site: Upper inner quadrant, Distance from Nipple: OBX|112|TX| 3.0 Centimeters (cm) OBX|113|TX| Lymphovascular Invasion: Present OBX|114|TX| Skin Invasion: Skin is uninvolved OBX|115|TX| In Situ Component: Present OBX|116|TX| In Situ Component Type: DCIS OBX|117|TX| Nuclear Grade: Grade I (low) OBX|118|TX| Necrosis: Present, focal (small foci or single cell OBX|119|TX| necrosis) OBX|120|TX| DCIS Extent: Extensive OBX|121|TX| DCIS Estimated Size: 2.5 mm OBX|122|TX| OBX|123|TX|MARGINS OBX|124|TX| Invasive Carcinoma Margins: Negative for invasive carcinoma OBX|125|TX| Distance from Closest Margin: 4 Millimeters (mm) OBX|126|TX| Closest Margin: Superior OBX|127|TX| DCIS Margins: Negative for DCIS OBX|128|TX| Distance of DCIS from Closest OBX|129|TX| Margin: 4 Millimeters (mm) OBX|130|TX| OBX|131|TX|LYMPH NODES, REGIONAL OBX|132|TX| Number of Lymph Nodes Examined OBX|133|TX| (sentinel and nonsentinel): 5 OBX|134|TX| Micro / Macro Metastasis: Present OBX|135|TX| Number of Lymph Nodes with OBX|136|TX| Micrometastases: 4 OBX|137|TX| Number of Lymph Nodes with OBX|138|TX| Macrometastases: 1 OBX|139|TX| Size of Largest Metastatic OBX|140|TX| Deposit: 2.5 Millimeters (mm) OBX|141|TX| OBX|142|TX|PATHOLOGIC STAGE OBX|143|TX| pT1a pN2a OBX|144|TX| OBX|145|TX|ANCILLARY STUDIES OBX|146|TX| Best Tumour Block: test OBX|147|TX| Biomarker Testing/Results: Not performed: test OBX|148|TX| OBX|149|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|150|TX|---------- End of Synoptic Report ---------- OBX|151|TX|-------- Breast DCIS, 5 -------- OBX|152|TX| OBX|153|TX|SPECIMEN OBX|154|TX| Procedure: Total mastectomy OBX|155|TX| Specimen Laterality: Right OBX|156|TX| OBX|157|TX|TUMOUR OBX|158|TX| Estimated Size (extent) of DCIS: testing testing OBX|159|TX| Histologic Type: Paget disease OBX|160|TX| Nuclear Grade: Grade II (intermediate) OBX|161|TX| Necrosis: Present, focal (small foci or single cell OBX|162|TX| necrosis) OBX|163|TX| OBX|164|TX|MARGINS OBX|165|TX| Negative for DCIS OBX|166|TX| Distance from Closest Margin: 50 Millimeters (mm) OBX|167|TX| Closest Margin: Inferior OBX|168|TX| OBX|169|TX|LYMPH NODES, REGIONAL OBX|170|TX| No lymph nodes present OBX|171|TX| OBX|172|TX|PATHOLOGIC STAGE OBX|173|TX| rpTis (Paget) pNX pM1 OBX|174|TX| pM Site(s): test test test OBX|175|TX| pM Report ID: testing testing OBX|176|TX| OBX|177|TX|ANCILLARY STUDIES OBX|178|TX| Best Tumour Block: test OBX|179|TX| Biomarker Testing/Results: Not performed: test test OBX|180|TX| OBX|181|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC February 2019 OBX|182|TX|---------- End of Synoptic Report ---------- OBX|183|TX| ____________________________________ OBX|184|TX| Brigette Rabel OBX|185|TX| Electronically signed: 28/Nov/2019 OBX|186|TX| OBX|187|TX|-------------------------------------------------------------------------------------------- OBX|188|TX| OBX|189|TX| OBX|190|TX| OBX|191|TX| OBX|192|TX| OBX|193|TX| OBX|194|TX| OBX|195|TX| OBX|196|TX| OBX|197|TX| OBX|198|TX| OBX|199|TX| OBX|200|TX| OBX|201|TX| OBX|202|TX| OBX|203|TX| OBX|204|TX| OBX|205|TX| OBX|206|TX| OBX|207|TX| OBX|208|TX| OBX|209|TX|  MSH|^~\&|PTH|ARH|||201911281040||ORU^R01|4115853|D|2.3|||AL|NE PID|1||AB00007506|AB7559|PTHTEST^SCANNING^ONE||19720801|F||||||||||AB000437/18|9875869973 PV1|1|O OBR|1|20077|00014919^19AS-1^PTH^19AS-1^20077||||20190102|||||||201901021032|S^SURGICAL SPECIMEN^SURGICAL|||||19AS-1||201911281040|||SOUT OBX|1|TX|Pathology Lab: Mission Memorial Hospital OBX|2|TX|Phone: Fax: OBX|3|TX| OBX|4|TX|Specimen Number: 19AS-1 OBX|5|TX| OBX|6|TX|DIAGNOSES OBX|7|TX|TESTING BIZTALK 2013 OBX|8|TX| OBX|9|TX|SYNOPTIC REPORT OBX|10|TX|-------- Breast Biomarkers, 2 -------- OBX|11|TX| OBX|12|TX|SPECIMEN OBX|13|TX| Block Tested: test OBX|14|TX| OBX|15|TX|BREAST BIOMARKER TESTS OBX|16|TX| Ki-67: Low (Less than 10%) OBX|17|TX| OBX|18|TX|METHODS OBX|19|TX| Cold Ischemia and Fixation Times OBX|20|TX| Meet the Requirements Specified in OBX|21|TX| the Latest Version of the ASCO / CAP OBX|22|TX| Guidelines: No OBX|23|TX| OBX|24|TX|---------- End of Synoptic Report ---------- OBX|25|TX| ____________________________________ OBX|26|TX| Brigette Rabel OBX|27|TX| Electronically signed: 28/Nov/2019 OBX|28|TX| OBX|29|TX|--------------------------------------------------------------------------------------------  MSH|^~\&|PTH|SMH|||201911281040||ORU^R01|4115854|D|2.3|||AL|NE PID|1||SM00040261|SM40228|LABTEST^ABDOH^||20160920|F||||||||||SM003631/18|9876478783 PV1|1|O OBR|1|23902|00018150^19AS-8^PTH^19AS-8^23902||||20190304|||||||201903041456|S^SURGICAL SPECIMEN^SURGICAL|||||19AS-8||201911281040|||SOUT OBX|1|TX|Pathology Lab: Abbotsford Regional Hospital OBX|2|TX|Phone: (604)851-4700x646545 Fax: (604)851-4858 OBX|3|TX| OBX|4|TX|Specimen Number: 19AS-8 OBX|5|TX| OBX|6|TX|DIAGNOSES OBX|7|TX|TESTING BIZTALK 2013 OBX|8|TX| OBX|9|TX|SYNOPTIC REPORT OBX|10|TX|-------- Endometrium - Hysterectomy, 1 -------- OBX|11|TX| OBX|12|TX|SPECIMEN OBX|13|TX| Procedure: Radical hysterectomy OBX|14|TX| OBX|15|TX|TUMOUR OBX|16|TX| Histologic Type: Endometrioid carcinoma with secretory OBX|17|TX| differentiation OBX|18|TX| Histologic Grade: FIGO grade 2 OBX|19|TX| Tumour Size: 3 Centimeters (cm) OBX|20|TX| Myometrial Invasion: Present OBX|21|TX| Depth of Invasion: 2 Millimeters (mm) OBX|22|TX| Myometrial Thickness: 2 Millimeters (mm) OBX|23|TX| Percentage of Myometrial Invasion: 100% OBX|24|TX| Cervical Stromal Invasion: Present OBX|25|TX| Other Tissue Involvement / Organ OBX|26|TX| Involvement: Not applicable OBX|27|TX| Lymph Vascular Invasion: Focal (2 or fewer) OBX|28|TX| OBX|29|TX|MARGINS OBX|30|TX| Parametrial / Paracervical Margin: Positive for carcinoma OBX|31|TX| OBX|32|TX|LYMPH NODES, REGIONAL OBX|33|TX| Number of Sentinel Node(s) Examined: 2 OBX|34|TX| Site of Sentinel Node(s) Examined: Pelvic OBX|35|TX| Laterality of Sentinel Node(s) OBX|36|TX| Examined: Right OBX|37|TX| Number of Sentinel Nodes with OBX|38|TX| Macrometastasis: 1 OBX|39|TX| Number of Sentinel Nodes with OBX|40|TX| Micrometastasis: 0 OBX|41|TX| Number of Sentinel Nodes with OBX|42|TX| Isolated Tumour Cells: 0 OBX|43|TX| Site of Sentinel Node(s) with OBX|44|TX| Tumour: Pelvic OBX|45|TX| Laterality of Sentinel Node(s) with OBX|46|TX| Tumour: Right OBX|47|TX| Pelvic Lymph Nodes (non-sentinel): No pelvic nodes present OBX|48|TX| Para-Aortic Lymph Nodes OBX|49|TX| (non-sentinel): No para-aortic nodes present OBX|50|TX| OBX|51|TX|PATHOLOGIC STAGE OBX|52|TX| pT2 pN1a OBX|53|TX| OBX|54|TX|ANCILLARY STUDIES OBX|55|TX| Best Tumour Block: test OBX|56|TX| Biomarker Testing: Performed, to follow: test OBX|57|TX| OBX|58|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|59|TX|---------- End of Synoptic Report ---------- OBX|60|TX|-------- Kidney - Nephrectomy, Partial or Radical, 2 -------- OBX|61|TX| OBX|62|TX|SPECIMEN COMMENT OBX|63|TX| Pertains To: V.7.0.0.6 OBX|64|TX| OBX|65|TX|SPECIMEN OBX|66|TX| Procedure: Radical nephrectomy OBX|67|TX| Specimen Laterality: Right OBX|68|TX| OBX|69|TX|TUMOUR OBX|70|TX| Tumour Focality: Unifocal OBX|71|TX| Tumour Size: 3 Centimeters (cm) OBX|72|TX| Histologic Type: Clear cell renal cell carcinoma OBX|73|TX| Histologic Grade (WHO / ISUP Grade): G3 OBX|74|TX| Tumour Extension: Tumour extension into inferior vena cava OBX|75|TX| Tumour Necrosis: Not identified OBX|76|TX| Lymphovascular Invasion: Not identified OBX|77|TX| Sarcomatoid Features: Not identified OBX|78|TX| Rhabdoid Features: Not identified OBX|79|TX| OBX|80|TX|MARGINS OBX|81|TX| Positive for invasive carcinoma OBX|82|TX| Margin(s): Renal sinus soft tissue margin OBX|83|TX| OBX|84|TX|LYMPH NODES, REGIONAL OBX|85|TX| No lymph nodes present OBX|86|TX| OBX|87|TX|PATHOLOGIC STAGE OBX|88|TX| pT3 pNX OBX|89|TX| OBX|90|TX|ANCILLARY STUDIES OBX|91|TX| Best Tumour Block: TEST OBX|92|TX| OBX|93|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|94|TX|---------- End of Synoptic Report ---------- OBX|95|TX|-------- Major Salivary Gland, 3 -------- OBX|96|TX| OBX|97|TX|SPECIMEN COMMENT OBX|98|TX| Pertains to: Testing v.7.0.0.6 OBX|99|TX| OBX|100|TX|SPECIMEN OBX|101|TX| Procedure: Parotidectomy, not specified OBX|102|TX| OBX|103|TX|TUMOUR OBX|104|TX| Tumour Site: Sublingual gland OBX|105|TX| Tumour Laterality: Bilateral OBX|106|TX| Tumour Focality: Unifocal OBX|107|TX| Histologic Type: Mucoepidermoid carcinoma, high grade OBX|108|TX| Tumour Size: 3 Centimeters (cm) OBX|109|TX| Macroscopic Tumour Extension: test OBX|110|TX| Lymphovascular Invasion: Present OBX|111|TX| Perineural Invasion: Present OBX|112|TX| OBX|113|TX|MARGINS OBX|114|TX| Negative for carcinoma OBX|115|TX| Distance of Tumour from Closest OBX|116|TX| Margin: 3 Millimeters (mm) OBX|117|TX| Margin: test OBX|118|TX| OBX|119|TX|LYMPH NODES, REGIONAL OBX|120|TX| Number of Lymph Nodes Examined: 4 OBX|121|TX| Number of Lymph Nodes Involved: Cannot be determined - test OBX|122|TX| Laterality of Lymph Nodes Involved: Cannot be determined - test OBX|123|TX| Size of Largest Metastatic Deposit: 3 Centimeters (cm) OBX|124|TX| Extranodal Extension (ENE): Not identified OBX|125|TX| OBX|126|TX|PATHOLOGIC STAGE OBX|127|TX| pT2 pNX OBX|128|TX| OBX|129|TX|ANCILLARY STUDIES OBX|130|TX| Best Tumour Block: test OBX|131|TX| OBX|132|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|133|TX|---------- End of Synoptic Report ---------- OBX|134|TX|-------- Colon and Rectum - Resection, 4 -------- OBX|135|TX| OBX|136|TX|SPECIMEN COMMENT OBX|137|TX| Pertains To: testing 7.0.0.18 OBX|138|TX| OBX|139|TX|SPECIMEN OBX|140|TX| Procedure: Right hemicolectomy OBX|141|TX| Macroscopic Tumour Perforation: Present OBX|142|TX| OBX|143|TX|TUMOUR OBX|144|TX| Tumour Site: Cecum OBX|145|TX| Histologic Type: Adenocarcinoma OBX|146|TX| Histologic Grade: G1: Well differentiated (Low grade) OBX|147|TX| Tumour Size: 3 Centimeters (cm) OBX|148|TX| Tumour Extension: Tumour invades submucosa OBX|149|TX| Lymphovascular Invasion: Present OBX|150|TX| Perineural Invasion: Present OBX|151|TX| Comment: testing tumour comment OBX|152|TX| OBX|153|TX|MARGINS OBX|154|TX| Proximal Margin: Negative for invasive carcinoma OBX|155|TX| Status of Non-Invasive Tumour at OBX|156|TX| Proximal Margin: Positive for intramucosal adenocarcinoma OBX|157|TX| Distal Margin: Negative for invasive carcinoma, OBX|158|TX| intramucosal adenocarcinoma, high-grade OBX|159|TX| dysplasia and adenoma OBX|160|TX| Radial or Mesenteric Margin: Negative for invasive carcinoma OBX|161|TX| Comment: testing optional margin comment OBX|162|TX| OBX|163|TX|LYMPH NODES, REGIONAL OBX|164|TX| Number of Lymph Nodes Examined: 8 OBX|165|TX| Number of Lymph Nodes Involved: 4 OBX|166|TX| Tumour Deposits: Present OBX|167|TX| Number of Deposits: 5 OBX|168|TX| Comment: testing lymph node comment OBX|169|TX| OBX|170|TX|TREATMENT EFFECT OBX|171|TX| No known presurgical therapy OBX|172|TX| OBX|173|TX|PATHOLOGIC STAGE OBX|174|TX| pT1 pN2a pM1 OBX|175|TX| OBX|176|TX|ANCILLARY STUDIES OBX|177|TX| Best Tumour Block: test OBX|178|TX| Biomarker Testing: Performed, to follow: test OBX|179|TX| OBX|180|TX|Based on AJCC/UICC TNM, 8th edition; CAP eCC June 2017 OBX|181|TX|---------- End of Synoptic Report ---------- OBX|182|TX| ____________________________________ OBX|183|TX| Brigette Rabel OBX|184|TX| Electronically signed: 28/Nov/2019 OBX|185|TX| OBX|186|TX|-------------------------------------------------------------------------------------------- OBX|187|TX| OBX|188|TX| OBX|189|TX| OBX|190|TX| OBX|191|TX| OBX|192|TX| OBX|193|TX| OBX|194|TX| OBX|195|TX| OBX|196|TX| OBX|197|TX| OBX|198|TX| OBX|199|TX| OBX|200|TX| OBX|201|TX| OBX|202|TX| OBX|203|TX| OBX|204|TX| OBX|205|TX| OBX|206|TX| OBX|207|TX| OBX|208|TX| OBX|209|TX|